Vascularized Bone Marrow Cellular Depletion or Discontinuity Abrogates Protection of Vascularized Composite Allografts in Nonhuman Primates

Background. Vascularized composite allografts (VCA) have demonstrated good clinical outcomes dependent on chronic immunosuppression. Previous work by our group and others supports that cotransplanted vascularized bone marrow (VBM) as a component of VCA offers immunologic protection to prolong graft...

Full description

Bibliographic Details
Main Authors: Nicole Shockcor, MD, Evan B. Buckingham, MD, Wessam Hassanein, MBBCH, Urmil Dhru, MSc, Ali Khalifeh, MD, Mehmet Uluer, MD, Jhade Woodall, MD, Philip Brazio, MD, Cynthia Drachenberg, MD, Arthur J. Nam, MD, Rolf N. Barth, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-02-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001107